Idexx Laboratories Inc (IDXX): R&D Expense
$251.21M
Year ended 2025-12-31
$261.46M
Trailing 12 months to 2026-06-30
-0.5%
3-year compound annual growth
+12.2%
5-year compound annual growth
+9.7%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $251.21M | +14.3% | 2026-02-20, From 2025-01-01 |
| 2024-12-31 | $219.79M | +15.1% | 2026-02-20, From 2024-01-01 |
| 2023-12-31 | $190.95M | -25.1% | 2026-02-20, From 2023-01-01 |
| 2022-12-31 | $254.82M | +58.3% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $161.01M | +14.0% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $141.25M | +6.0% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $133.19M | +13.0% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $117.86M | +8.0% | 2021-02-12, From 2018-01-01 |
| 2017-12-31 | $109.18M | +8.0% | 2020-02-14, From 2017-01-01 |
| 2016-12-31 | $101.12M | +1.4% | 2019-02-15, From 2016-01-01 |
| 2015-12-31 | $99.68M | +1.4% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $98.26M | +11.7% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $88.00M | +7.3% | 2016-02-17, From 2013-01-01 |
| 2012-12-31 | $82.01M | +7.9% | 2015-02-17, From 2012-01-01 |
| 2011-12-31 | $76.04M | +10.9% | 2014-02-18, From 2011-01-01 |
| 2010-12-31 | $68.60M | +5.3% | 2013-02-19, From 2010-01-01 |
| 2009-12-31 | $65.12M | -7.9% | 2012-02-17, From 2009-01-01 |
| 2008-12-31 | $70.67M | n/a | 2011-02-22, From 2008-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $251.21M | +14.3% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $186.20M | -14.9% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $177.31M | +5.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $18.40M | -12.8% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $106.80M | -5.8% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $388.86M | -16.6% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $2.20M | -20.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $3.04M | -22.0% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $2.88M | -11.9% |
Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗